Morgan Stanley Edgewise Therapeutics, Inc. Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Morgan Stanley holds 418,131 shares of EWTX stock, worth $13.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

418,131

Previous 249,974 67.27%

Holding current value

$13.5 Million

Previous $4.5 Million 147.87%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$15.88 - $29.5 $2.67 Million - $4.96 Million	168,157 Added 67.27%	418,131 $11.2 Million
Q2 2024 Oct 17, 2024	SELL	$15.08 - $21.23 $1.88 Million - $2.65 Million	-124,744 Reduced 33.29%	249,974 $4.5 Million
Q2 2024 Aug 14, 2024	SELL	$15.08 - $21.23 $1.88 Million - $2.65 Million	-124,744 Reduced 33.29%	249,974 $4.5 Million
Q1 2024 Oct 17, 2024	BUY	$9.25 - $19.97 $1.15 Million - $2.49 Million	124,744 Added 49.9%	374,718 $6.83 Million
Q1 2024 Aug 16, 2024	BUY	$9.25 - $19.97 $1.38 Million - $2.99 Million	149,539 Added 66.41%	374,718 $6.83 Million
Q1 2024 May 15, 2024	BUY	$9.25 - $19.97 $1.38 Million - $2.99 Million	149,539 Added 66.41%	374,718 $6.83 Million
Q4 2023 Aug 16, 2024	SELL	$5.51 - $12.1 $136,620 - $300,019	-24,795 Reduced 9.92%	225,179 $2.46 Million
Q4 2023 Feb 13, 2024	BUY	$5.51 - $12.1 $838,115 - $1.84 Million	152,108 Added 208.16%	225,179 $2.46 Million
Q3 2023 Nov 15, 2023	SELL	$5.73 - $7.69 $156,555 - $210,106	-27,322 Reduced 27.22%	73,071 $418,000
Q2 2023 Aug 14, 2023	BUY	$5.71 - $10.29 $206,245 - $371,674	36,120 Added 56.2%	100,393 $778,000
Q1 2023 May 15, 2023	BUY	$6.66 - $11.33 $26,453 - $45,002	3,972 Added 6.59%	64,273 $428,000
Q4 2022 Feb 14, 2023	SELL	$7.58 - $11.08 $336,824 - $492,350	-44,436 Reduced 42.43%	60,301 $539,000
Q3 2022 Nov 14, 2022	BUY	$8.08 - $13.58 $466,805 - $784,557	57,773 Added 123.02%	104,737 $1.03 Million
Q2 2022 Oct 27, 2022	BUY	$5.67 - $9.87 $141,687 - $246,641	24,989 Added 113.72%	46,964 $374,000
Q2 2022 Aug 15, 2022	BUY	$5.67 - $9.87 $141,687 - $246,641	24,989 Added 113.72%	46,964 $374,000
Q1 2022 Oct 27, 2022	SELL	$9.1 - $18.97 $227,399 - $474,041	-24,989 Reduced 53.21%	21,975 $214,000
Q1 2022 May 13, 2022	BUY	$9.1 - $18.97 $43,661 - $91,018	4,798 Added 27.93%	21,975 $214,000
Q4 2021 Feb 14, 2022	BUY	$14.41 - $22.41 $235,041 - $365,529	16,311 Added 1883.49%	17,177 $262,000
Q3 2021 Nov 15, 2021	BUY	$14.11 - $24.1 $12,219 - $20,870	866 New	866 $14,000

Others Institutions Holding EWTX

# of Institutions

191

Shares Held

100M

Call Options Held

2.17M

Put Options Held

410K

View Full List

About Edgewise Therapeutics, Inc.

Ticker EWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 63,171,700
Market Cap $2.03B
Description
Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...

More about EWTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account